Results 141 to 150 of about 14,877 (300)

CD2: ABCIXIMAB IN PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY: A MULTICENTER OBSERVATIONAL STUDY

, 1999
Vlasses Ph, C Chen, Harlan Krumholz, Douglas Cocks, David M. McGee, D. B. Morton   +5 more
openalex   +1 more source

A Case of Successful Primary Coronary Intervention for the Total Occlusion of Left Main Stem with the Aid of Abciximab [PDF]

, 2001
Myung Ho Jeong, Young Keun Ahn, Jong Cheol Park, Byoung Hee Ahn, Kook Joo Na, Nam Ho Kim, Kun Hyung Kim, Jeong Gwan Cho, Jong Chun Park, Sang Hyung Kim, Jung Chaee Kang   +10 more
openalex   +1 more source

Tirofiban-induced thrombocytopenia. [PDF]

Ann Med, 2023
Wang J, Zou D.
europepmc   +1 more source

Rescue use of abciximab improves regional left ventricular function after early incomplete reperfusion in acute myocardial infarction [PDF]

, 2001
Goo‐Yeong Cho, Cheol W. Lee, Myeong‐Ki Hong, Duk‐Hyun Kang, Jae‐Kwan Song, Jae‐Joong Kim, Seong‐Wook Park, Seung‐Jung Park   +7 more
openalex   +1 more source

Economic Assessment of Platelet Glycoprotein IIb/IIIa Receptor Blockade With Abciximab and Low-Dose Heparin During Percutaneous Coronary Revascularization

, 2000
A. Michael Lincoff, Daniel B. Mark, James E. Tcheng, Robert M. Califf, Mohan Bala, Keaven M. Anderson, Linda Davidson‐Ray, J. David Knight, Catherine F. Cabot, Eric J. Topol   +9 more
openalex   +1 more source

PLATELET ANTIAGGREGANTS: MECHANISMS OF ACTION AND USE ASOCIED RISKS

Vitae, 2009
Cardiovascular diseases are the main cause of death in the world. Next to efforts to reduce the cardiovascular risk factors, several drugs are resorted to decrease morbimortality associated to these diseases: antihypertensive, antidiabetic, hypolipemiant
Iván F. PALOMO G, Constanza I. TORRES U., Rodrigo E. MOORE-Carrasco., Marcelo A. ALARCÓN L., Patricio J. MARAGAÑO L.   +4 more
doaj  

Intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction: the INFUSE-AMI randomized trial.

Journal of the American Medical Association (JAMA), 2012
G. Stone, A. Maehara, B. Witzenbichler, J. Godlewski, H. Parise, J. Dambrink, A. Ochała, Trevor W Carlton, Ecaterina Cristea, S. Wolff, S. Brener, S. Chowdhary, M. El-omar, T. Neunteufl, D. Metzger, T. Karwoski, J. Dizon, R. Mehran, C. Gibson   +18 more
semanticscholar   +1 more source

Differential inhibition of adenosine diphosphate– versus thrombin receptor–activating peptide–stimulated platelet fibrinogen binding by abciximab due to different glycoprotein IIb/IIIa activation kinetics [PDF]

, 2001
Artur‐Aron Weber, Karsten Schrör
openalex   +1 more source

Administration of abciximab to patients receiving tirofiban or eptifibatide: effect on platelet function [PDF]

, 2001
Eli I. Lev, Julio Osende, Merwin Richard, Jonathan A. Robbins, Jenny A. Delfin, O Rodríguez, Sanjeev Sharma, Tim Jayasundera, Juan J. Badimón, Jonathan D. Marmur   +9 more
openalex   +1 more source

Facilitation of early percutaneous coronary intervention after reteplase with or without abciximab in acute myocardial infarction

, 2000
Howard C. Herrmann, David J. Moliterno, E. Magnus Ohman, Amanda Stebbins, Christopher Bode, Amadeo Betriu, Florian Forycki, Jerry S Miklin, William Bachinsky, A. Michael Lincoff, Robert M. Califf, Eric J. Topol   +11 more
openalex   +1 more source